LARIMAR THERAPEUTICS INC (LRMR) Stock Earnings Estimates

USA Nasdaq NASDAQ:LRMR • US5171251003

3.37 USD
+0.3 (+9.77%)
At close: Feb 6, 2026
3.36 USD
-0.01 (-0.3%)
Pre-Market: 2/9/2026, 4:03:24 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LRMR revenue by date.LRMR revenue by date.
N/AN/AN/A
1,218.28%
N/A
516.10%
N/A
110.28%
N/A
71.70%
N/A
-6.82%
N/A
-23.80%
N/A
5.91%
EBITDA
YoY % growth
LRMR ebitda by date.LRMR ebitda by date.
-73.743M-58.013M
21.33%
-52.811M
8.97%
-60.861M
-15.24%
-39.838M
34.54%
-42.649M
-7.06%
-50.139M
-17.56%
-36.208M
27.78%
-41.447M
-14.47%
-90.572M
-118.52%
N/A
-57.39%
N/A
-2.90%
N/A
-3.26%
N/A
59.14%
N/A
254.44%
N/A
247.67%
N/A
58.58%
N/AN/A
EBIT
YoY % growth
LRMR ebit by date.LRMR ebit by date.
-73.813M-58.225M
21.12%
-52.999M
8.98%
-61.122M
-15.33%
-40.101M
34.39%
-42.804M
-6.74%
-50.465M
-17.90%
-36.526M
27.62%
-41.758M
-14.32%
-90.89M
-117.66%
N/A
-69.72%
N/A
-17.33%
N/A
5.00%
N/A
81.29%
N/A
656.80%
N/A
179.66%
N/A
-22.87%
N/A
-23.06%
N/A
9.71%
Operating Margin
LRMR operating margin by date.LRMR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
LRMR eps by date.LRMR eps by date.
-33.24-25.44
23.47%
-22.92
9.91%
-23.40
-2.09%
-13.20
43.59%
-3.94
70.15%
-2.97
24.62%
-1.54
48.15%
-0.85
44.81%
-1.30
-52.94%
N/A
-53.18%
N/A
6.87%
N/A
14.80%
N/A
13.49%
N/A
-32.09%
N/A
29.94%
N/A
33.87%
N/A
47.56%
N/A
53.49%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.50
-11.03%
-0.51
-10.62%
-0.49
-18.31%
-0.48
21.89%
-0.50
0.68%
-0.50
2.38%
-0.47
3.48%
-0.46
4.20%
-0.42
16.34%
Revenue
Q2Q % growth
N/A7.164M12.818M12.637M
EBITDA
Q2Q % growth
-34.813M
-12.39%
-35.07M
-12.76%
-37.391M
-35.39%
-39.246M
20.29%
-45.696M
-31.26%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-43.091M
-37.70%
-43.898M
-40.75%
-43.103M
-55.09%
-43.305M
12.51%
-45.339M
-5.22%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.61
-154.17%
-0.41-0.20-48.03%
Q2 2025
Q2Q % growth
-0.41
-20.59%
-0.490.0816.29%
Q1 2025
Q2Q % growth
-0.46
-70.37%
-0.43-0.03-7.82%
Q4 2024
Q2Q % growth
-0.45
-50.00%
-0.32-0.13-39.14%
Q3 2024
Q2Q % growth
-0.24
-14.29%
-0.380.1437.25%
Q2 2024
Q2Q % growth
-0.34
-78.95%
-0.31-0.03-9.17%
Q1 2024
Q2Q % growth
-0.27
-80.00%
-0.24-0.03-12.64%
Q4 2023
Q2Q % growth
-0.30
-42.86%
-0.25-0.05-18.88%
Q3 2023
Q2Q % growth
-0.21
43.24%
-0.230.027.84%
Q2 2023
Q2Q % growth
-0.19
59.57%
-0.200.014.47%
Q1 2023
Q2Q % growth
-0.15
69.39%
-0.250.1040.22%
Q4 2022
Q2Q % growth
-0.21
58.00%
-0.280.0724.45%
Q3 2022
Q2Q % growth
-0.37
59.78%
-0.430.0613.63%
Q2 2022
Q2Q % growth
-0.47
40.51%
-0.580.1119.63%
Q1 2022
Q2Q % growth
-0.49
35.53%
-0.520.035.81%
Q4 2021
Q2Q % growth
-0.50
43.82%
-0.730.2331.60%
Q3 2021
Q2Q % growth
-0.92
-43.75%
-0.66-0.26-40.20%
Q2 2021
Q2Q % growth
-0.79
34.71%
-0.76-0.03-3.73%
Q1 2021
Q2Q % growth
-0.76
36.67%
-0.880.1213.86%
Q4 2020
Q2Q % growth
-0.89 -0.71-0.18-24.65%
LRMR Yearly EPS VS EstimatesLRMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
LRMR Yearly Revenue VS EstimatesLRMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.36% 1.82% 0.6% -17.61%
RevenueN/A N/A N/A N/A